EUVIMEDEUVIMED entdecken
Crossref

Diagnostic utility of APRI , FIB ‐4, and FIB ‐5 in intrahepatic cholestasis of pregnancy: A retrospective case–control study

Sevil Cicek iD, Bilge Kapudere iD, Yasemin Beyza Kaya Parspancı iD, Zehra Tavukcuoglu iD, Omer Gokhan Eyisoy iD, Reyhan Ayaz iD

International Journal of Gynecology & Obstetrics · 2026-07 · 174 (1) · 253-263

DOI: 10.1002/ijgo.70807 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, online erschienen am 23.01.2026. Verfasst von Sevil Cicek und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Perinatology, Goztepe Professor Dr. Süleyman Yalçın Training and Research Hospital, Istanbul, Turkey. Hauptthemen laut MEDLINE: Cholestasis, Intrahepatic, Pregnancy Complications, Aspartate Aminotransferases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To investigate the diagnostic utility of three non‐invasive hepatic fibrosis indices—aminotransferase‐to‐platelet ratio index (APRI), Fibrosis‐4 (FIB‐4), and FIB‐5—in pregnancies complicated by intrahepatic cholestasis of pregnancy (ICP), and exploratory analysis of neonatal outcomes.

Methods

This retrospective case–control study included 217 pregnant women who delivered at Göztepe Prof. Dr. Süleyman Yalçın City Hospital, a tertiary care center affiliated with Istanbul Medeniyet University, between September 2018 and February 2024. The study population was divided into two groups: 105 women diagnosed with ICP and 112 pregnant women without ICP who served as controls. The diagnosis of ICP was based on clinical pruritus, elevated serum bile acid levels (>10 μmol/L), and abnormal liver function tests. Women with pre‐eclampsia, HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome, coagulopathy, hepatitis, multiple pregnancies, or other hepatic conditions were excluded. Laboratory parameters including aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), albumin, and platelet counts were used to calculate APRI, FIB‐4, and FIB‐5 scores. Statistical analyses included Mann–Whitney U ‐tests for group comparisons and receiver operating characteristics (ROC) curve analyses to determine the diagnostic performance of each score.

Results

APRI and FIB‐5 scores were significantly higher in the ICP group compared with controls, whereas FIB‐4 showed a smaller between‐group difference ( P < 0.001 for APRI and FIB‐5; P = 0.022 for FIB‐4). ROC analysis demonstrated good diagnostic performance for APRI (area nder the curve [AUC] = 0.902; cut‐off = 0.39; sensitivity = 82%; specificity = 89%) and moderate performance for FIB‐5 (AUC = 0.718; cut‐off = −1.84; sensitivity = 67%; specificity = 70%). FIB‐4 showed lower diagnostic value (AUC = 0.590). Elevated scores were also associated with adverse neonatal outcomes, increased rates of preterm birth, and greater need for neonatal intensive care.

Conclusion

APRI, FIB‐4, and FIB‐5 are elevated in pregnancies affected by ICP and may serve as supportive, non‐invasive markers reflecting hepatocellular stress and hepatic involvement. Among these indices, APRI showed the best diagnostic performance, FIB‐5 demonstrated moderate discriminative ability, and FIB‐4 had limited diagnostic utility. These indices may provide clinicians with additional information when evaluating hepatic dysfunction and may be associated with neonatal outcomes, although they are not validated prognostic tools. Prospective studies are warranted to further validate their clinical utility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholestasis, IntrahepaticPregnancy ComplicationsAspartate AminotransferasesHumansFemalePregnancyRetrospective StudiesCase-Control StudiesAdultPlatelet CountROC CurveBiomarkersAlanine TransaminaseLiver Function TestsPregnancy OutcomeAlkaline PhosphataseSensitivity and Specificity

Stichwörter der Autor:innen

alanine aminotransferaseaspartate aminotransferasebile acidsintrahepatic cholestasis of pregnancyliver function testspregnancy complications

Substanzen

Aspartate AminotransferasesBiomarkersAlanine TransaminaseAlkaline Phosphatase

Autor:innen und Institutionen

  • Department of Perinatology, Goztepe Professor Dr. Süleyman Yalçın Training and Research Hospital, Istanbul, Turkey.
  • Department of Perinatology, Clinic of Obstetrics and Gynecology, Yozgat City Hospital, Yozgat, Turkey.

ORCID-Profile: Sevil Cicek, Bilge Kapudere, Yasemin Beyza Kaya Parspancı, Zehra Tavukcuoglu, Omer Gokhan Eyisoy, Reyhan Ayaz

Zitieren

APA

Cicek, S., Kapudere, B., Parspancı, Y. B. K., Tavukcuoglu, Z., Eyisoy, O. G., & Ayaz, R. (2026). Diagnostic utility of APRI , FIB ‐4, and FIB ‐5 in intrahepatic cholestasis of pregnancy: A retrospective case–control study. International Journal of Gynecology & Obstetrics, 174(1), 253-263. https://doi.org/10.1002/ijgo.70807

Vancouver

Cicek S, Kapudere B, Parspancı YBK, Tavukcuoglu Z, Eyisoy OG, Ayaz R. Diagnostic utility of APRI , FIB ‐4, and FIB ‐5 in intrahepatic cholestasis of pregnancy: A retrospective case–control study. International Journal of Gynecology & Obstetrics. 2026;174(1):253-263. doi:10.1002/ijgo.70807

BibTeX
@article{Cicek2026,
  author = {Cicek, Sevil and Kapudere, Bilge and Parspancı, Yasemin Beyza Kaya and Tavukcuoglu, Zehra and Eyisoy, Omer Gokhan and Ayaz, Reyhan},
  title = {Diagnostic utility of APRI , FIB ‐4, and FIB ‐5 in intrahepatic cholestasis of pregnancy: A retrospective case–control study},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2026},
  volume = {174},
  number = {1},
  pages = {253--263},
  doi = {10.1002/ijgo.70807}
}
Kostenlos starten →